FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2029806129> ?p ?o ?g. }

• W2029806129 endingPage "2814" @default.
• W2029806129 startingPage "2806" @default.
• W2029806129 abstract "Metastatic breast cancer chemotherapy in the elderly is considered effective in carefully selected patients, but there is little data regarding its effect in vulnerable patients.We evaluated tumour response (primary endpoint), feasibility and outcomes after six courses of an adapted dose of pegylated liposomal doxorubicin (PLD) (40 mg/m(2) every 28 days) as first-line chemotherapy for hormone-resistant MBC.Of 60 patients >70 years (median 77 years), 15% had performance status ≥2 and 73% had visceral metastases. Geriatric assessment included: ≥2 comorbidities, 42%; ≥1 deficiency in Activities of Daily Living (ADL), 10% and Instrumental ADL (IADL), 82%; living in residential homes, 12%; albumin <35 g/L, 17%; body mass index (BMI) <21, 20%; depression, 17%; and lymphocytes ≤1 × 10(3)/mm(3), 27%. Complete response, partial response and stable disease were observed in 5%, 15% and 60%, respectively, but only 48% completed six cycles. Treatment discontinuations were mostly due to disease progression (18%) and non-haematological (NH) toxicities (22%). Eight patients died during treatment (three possibly related to PLD), and 15 had unplanned hospital admissions. Exploratory analyses to identify geriatric covariates associated with treatment outcomes revealed severe haematological toxicities significantly correlated with lymphocytes ≤1 × 10(3)/mm(3). NH toxicities correlated with age ≥80 years and living in residential homes. Progression-free survival (median 6.1 months) decreased with age, deficiency in IADL, cardiac dysfunction and living in residential homes. Overall survival (median 15.7 months) also decreased with living in residential homes.Despite manageable haematological toxicities and expected response rates, PLD feasibility was poor in unselected elderly patients." @default.
• W2029806129 created "2016-06-24" @default.
• W2029806129 creator A5000170844 @default.
• W2029806129 creator A5001484228 @default.
• W2029806129 creator A5004452040 @default.
• W2029806129 creator A5005973748 @default.
• W2029806129 creator A5012670853 @default.
• W2029806129 creator A5040171322 @default.
• W2029806129 creator A5041911544 @default.
• W2029806129 creator A5050181071 @default.
• W2029806129 creator A5061048782 @default.
• W2029806129 creator A5061807618 @default.
• W2029806129 creator A5071961833 @default.
• W2029806129 creator A5077714048 @default.
• W2029806129 creator A5083630544 @default.
• W2029806129 creator A5085758096 @default.
• W2029806129 date "2013-09-01" @default.
• W2029806129 modified "2023-10-01" @default.
• W2029806129 title "Impact of geriatric risk factors on pegylated liposomal doxorubicin tolerance and efficacy in elderly metastatic breast cancer patients: Final results of the DOGMES multicentre GINECO trial" @default.
• W2029806129 cites W1492360552 @default.
• W2029806129 cites W1519481845 @default.
• W2029806129 cites W1533177716 @default.
• W2029806129 cites W1804680040 @default.
• W2029806129 cites W1885425707 @default.
• W2029806129 cites W1970357701 @default.
• W2029806129 cites W1971008772 @default.
• W2029806129 cites W1974704788 @default.
• W2029806129 cites W1984695410 @default.
• W2029806129 cites W1999533878 @default.
• W2029806129 cites W2005967824 @default.
• W2029806129 cites W2015815662 @default.
• W2029806129 cites W2019242507 @default.
• W2029806129 cites W2025383700 @default.
• W2029806129 cites W2029409133 @default.
• W2029806129 cites W2066072138 @default.
• W2029806129 cites W2088882392 @default.
• W2029806129 cites W2089726740 @default.
• W2029806129 cites W2092930296 @default.
• W2029806129 cites W2096451984 @default.
• W2029806129 cites W2096593771 @default.
• W2029806129 cites W2101742864 @default.
• W2029806129 cites W2107243894 @default.
• W2029806129 cites W2120083524 @default.
• W2029806129 cites W2142660045 @default.
• W2029806129 cites W2153294383 @default.
• W2029806129 cites W2153302882 @default.
• W2029806129 cites W2165782026 @default.
• W2029806129 cites W2168692224 @default.
• W2029806129 cites W2331849216 @default.
• W2029806129 cites W4249194292 @default.
• W2029806129 doi "https://doi.org/10.1016/j.ejca.2013.04.027" @default.
• W2029806129 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23735702" @default.
• W2029806129 hasPublicationYear "2013" @default.
• W2029806129 type Work @default.
• W2029806129 sameAs 2029806129 @default.
• W2029806129 citedByCount "29" @default.
• W2029806129 countsByYear W20298061292013 @default.
• W2029806129 countsByYear W20298061292014 @default.
• W2029806129 countsByYear W20298061292015 @default.
• W2029806129 countsByYear W20298061292016 @default.
• W2029806129 countsByYear W20298061292017 @default.
• W2029806129 countsByYear W20298061292018 @default.
• W2029806129 countsByYear W20298061292019 @default.
• W2029806129 countsByYear W20298061292021 @default.
• W2029806129 countsByYear W20298061292022 @default.
• W2029806129 countsByYear W20298061292023 @default.
• W2029806129 crossrefType "journal-article" @default.
• W2029806129 hasAuthorship W2029806129A5000170844 @default.
• W2029806129 hasAuthorship W2029806129A5001484228 @default.
• W2029806129 hasAuthorship W2029806129A5004452040 @default.
• W2029806129 hasAuthorship W2029806129A5005973748 @default.
• W2029806129 hasAuthorship W2029806129A5012670853 @default.
• W2029806129 hasAuthorship W2029806129A5040171322 @default.
• W2029806129 hasAuthorship W2029806129A5041911544 @default.
• W2029806129 hasAuthorship W2029806129A5050181071 @default.
• W2029806129 hasAuthorship W2029806129A5061048782 @default.
• W2029806129 hasAuthorship W2029806129A5061807618 @default.
• W2029806129 hasAuthorship W2029806129A5071961833 @default.
• W2029806129 hasAuthorship W2029806129A5077714048 @default.
• W2029806129 hasAuthorship W2029806129A5083630544 @default.
• W2029806129 hasAuthorship W2029806129A5085758096 @default.
• W2029806129 hasConcept C121608353 @default.
• W2029806129 hasConcept C126322002 @default.
• W2029806129 hasConcept C143998085 @default.
• W2029806129 hasConcept C1862650 @default.
• W2029806129 hasConcept C203092338 @default.
• W2029806129 hasConcept C2775930923 @default.
• W2029806129 hasConcept C2776694085 @default.
• W2029806129 hasConcept C2776907518 @default.
• W2029806129 hasConcept C530470458 @default.
• W2029806129 hasConcept C535046627 @default.
• W2029806129 hasConcept C71924100 @default.
• W2029806129 hasConcept C79544238 @default.
• W2029806129 hasConceptScore W2029806129C121608353 @default.
• W2029806129 hasConceptScore W2029806129C126322002 @default.
• W2029806129 hasConceptScore W2029806129C143998085 @default.
• W2029806129 hasConceptScore W2029806129C1862650 @default.
• W2029806129 hasConceptScore W2029806129C203092338 @default.

• next